| Product Code: ETC7642940 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Veterinary Intravenous (IV) Solutions Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Veterinary Intravenous (IV) Solutions Market - Industry Life Cycle |
3.4 Ireland Veterinary Intravenous (IV) Solutions Market - Porter's Five Forces |
3.5 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.8 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Veterinary Intravenous (IV) Solutions Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership in Ireland |
4.2.2 Growing awareness about veterinary healthcare |
4.2.3 Rise in demand for advanced veterinary treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for veterinary products |
4.3.2 High cost associated with veterinary IV solutions |
4.3.3 Limited availability of specialized veterinary IV solutions |
5 Ireland Veterinary Intravenous (IV) Solutions Market Trends |
6 Ireland Veterinary Intravenous (IV) Solutions Market, By Types |
6.1 Ireland Veterinary Intravenous (IV) Solutions Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Isotonic crystalloids, 2021- 2031F |
6.1.4 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Synthetic colloids, 2021- 2031F |
6.1.5 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Blood products, 2021- 2031F |
6.1.6 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Dextrose solutions, 2021- 2031F |
6.1.7 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Parenteral nutrition, 2021- 2031F |
6.2 Ireland Veterinary Intravenous (IV) Solutions Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Diabetic Ketoacidosis, 2021- 2031F |
6.2.3 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Pancreatitis, 2021- 2031F |
6.2.4 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Anthrax, 2021- 2031F |
6.2.5 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Chronic Kidney Disease, 2021- 2031F |
6.2.6 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Veterinary Intravenous (IV) Solutions Market, By Animal Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Companion Animals, 2021- 2031F |
6.3.3 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Production Animals, 2021- 2031F |
6.4 Ireland Veterinary Intravenous (IV) Solutions Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Veterinary Hospitals, 2021- 2031F |
6.4.3 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.4 Ireland Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Veterinary Intravenous (IV) Solutions Market Import-Export Trade Statistics |
7.1 Ireland Veterinary Intravenous (IV) Solutions Market Export to Major Countries |
7.2 Ireland Veterinary Intravenous (IV) Solutions Market Imports from Major Countries |
8 Ireland Veterinary Intravenous (IV) Solutions Market Key Performance Indicators |
8.1 Number of veterinary clinics offering IV solutions |
8.2 Adoption rate of advanced veterinary treatments |
8.3 Frequency of veterinary conferences and workshops attended by professionals |
9 Ireland Veterinary Intravenous (IV) Solutions Market - Opportunity Assessment |
9.1 Ireland Veterinary Intravenous (IV) Solutions Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ireland Veterinary Intravenous (IV) Solutions Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Ireland Veterinary Intravenous (IV) Solutions Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
9.4 Ireland Veterinary Intravenous (IV) Solutions Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Veterinary Intravenous (IV) Solutions Market - Competitive Landscape |
10.1 Ireland Veterinary Intravenous (IV) Solutions Market Revenue Share, By Companies, 2024 |
10.2 Ireland Veterinary Intravenous (IV) Solutions Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here